• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

罕见的胸部癌症,包括腹膜间皮瘤。

Rare thoracic cancers, including peritoneum mesothelioma.

机构信息

Department of Registry and Research, Comprehensive Cancer Centre The Netherlands, PO Box 330, 9700 AH Groningen, The Netherlands.

出版信息

Eur J Cancer. 2012 May;48(7):949-60. doi: 10.1016/j.ejca.2012.02.047. Epub 2012 Mar 9.

DOI:10.1016/j.ejca.2012.02.047
PMID:22406029
Abstract

Rare thoracic cancers include those of the trachea, thymus and mesothelioma (including peritoneum mesothelioma). The aim of this study was to describe the incidence, prevalence and survival of rare thoracic tumours using a large database, which includes cancer patients diagnosed from 1978 to 2002, registered in 89 population-based cancer registries (CRs) and followed-up to 31st December 2003. Over 17,688 cases of rare thoracic cancers were selected based on the list of the RACECARE project. Mesothelioma was the most common tumour (19 per million per year) followed by epithelial tumours of the trachea and thymus (1.3 and 1.7, respectively). The age standardised incidence rates of epithelial tumours of the trachea was double in Eastern and Southern Europe versus the other European regions: 2 per million per year. Epithelial tumours of the thymus had the lowest incidence in Northern and Eastern Europe and UK and Ireland(1) and somewhat higher incidence in Central and Southern Europe.(2) Highest incidence in mesothelioma was seen in UK and Ireland(23) and lowest in Eastern Europe.(4) Patients with tumours of the thymus had the best prognosis (1-year survival 85%, 66% at 5 years). Five year survival was lowest for the mesothelioma 5% compared to 14% of patients with tumours of the trachea. Mesothelioma was the most prevalent rare cancer (12,000 cases), followed by thymus (7000) and trachea (1400). Cancer Registry (CR) data play an important role in revealing the burden of rare thoracic cancers and monitoring the effect of regulations on asbestos use and smoking related policies.

摘要

罕见的胸部肿瘤包括气管、胸腺和间皮瘤(包括腹膜间皮瘤)。本研究的目的是使用一个大型数据库描述罕见胸部肿瘤的发病率、患病率和生存率,该数据库包括 1978 年至 2002 年诊断的癌症患者,登记在 89 个基于人群的癌症登记处(CR)中,并随访至 2003 年 12 月 31 日。根据 RACECARE 项目的清单,选择了超过 17688 例罕见的胸部癌症病例。间皮瘤是最常见的肿瘤(每年每百万 19 例),其次是气管和胸腺的上皮肿瘤(分别为 1.3 和 1.7)。气管上皮肿瘤的年龄标准化发病率在东欧和南欧是其他欧洲地区的两倍:每年每百万 2 例。胸腺上皮肿瘤在北欧和东欧以及英国和爱尔兰的发病率最低(1),在中欧和南欧的发病率略高(2)。间皮瘤的发病率最高见于英国和爱尔兰(23),最低见于东欧(4)。胸腺肿瘤患者的预后最好(1 年生存率 85%,5 年生存率 66%)。间皮瘤患者的 5 年生存率最低,为 5%,而气管肿瘤患者的 5 年生存率为 14%。间皮瘤是最常见的罕见癌症(12000 例),其次是胸腺(7000 例)和气管(1400 例)。癌症登记处(CR)数据在揭示罕见胸部癌症的负担和监测石棉使用法规和与吸烟相关政策的效果方面发挥着重要作用。

相似文献

1
Rare thoracic cancers, including peritoneum mesothelioma.罕见的胸部癌症,包括腹膜间皮瘤。
Eur J Cancer. 2012 May;48(7):949-60. doi: 10.1016/j.ejca.2012.02.047. Epub 2012 Mar 9.
2
Italian cancer figures--Report 2015: The burden of rare cancers in Italy.意大利癌症数据——2015年报告:意大利罕见癌症的负担
Epidemiol Prev. 2016 Jan-Feb;40(1 Suppl 2):1-120. doi: 10.19191/EP16.1S2.P001.035.
3
Survival of malignant mesothelioma and other rare thoracic cancers in Germany and the United States: A population-based study.德国和美国恶性间皮瘤和其他罕见胸部癌症的生存情况:一项基于人群的研究。
Int J Cancer. 2020 Sep 15;147(6):1548-1558. doi: 10.1002/ijc.32931. Epub 2020 Mar 3.
4
Descriptive epidemiology of malignant mucosal and uveal melanomas and adnexal skin carcinomas in Europe.欧洲恶性黏膜和葡萄膜黑色素瘤及附属器皮肤癌的描述性流行病学。
Eur J Cancer. 2012 May;48(8):1167-75. doi: 10.1016/j.ejca.2011.10.004. Epub 2011 Nov 25.
5
Rare cancers of the head and neck area in Europe.欧洲头颈部罕见癌症。
Eur J Cancer. 2012 Apr;48(6):783-96. doi: 10.1016/j.ejca.2011.08.021. Epub 2011 Nov 1.
6
Carcinoma of endocrine organs: results of the RARECARE project.内分泌器官癌:RARECARE 项目的结果。
Eur J Cancer. 2012 Sep;48(13):1923-31. doi: 10.1016/j.ejca.2012.01.029. Epub 2012 Feb 21.
7
Rare cancers are not so rare: the rare cancer burden in Europe.罕见癌症并不罕见:欧洲的罕见癌症负担。
Eur J Cancer. 2011 Nov;47(17):2493-511. doi: 10.1016/j.ejca.2011.08.008. Epub 2011 Oct 25.
8
Incidence and survival trends for malignant pleural and peritoneal mesothelioma, Australia, 1982-2009.1982 - 2009年澳大利亚恶性胸膜和腹膜间皮瘤的发病率及生存趋势
Occup Environ Med. 2016 Mar;73(3):187-94. doi: 10.1136/oemed-2015-103309. Epub 2016 Jan 22.
9
Epidemiology of glial and non-glial brain tumours in Europe.欧洲神经胶质瘤和非神经胶质瘤脑肿瘤的流行病学。
Eur J Cancer. 2012 Jul;48(10):1532-42. doi: 10.1016/j.ejca.2011.12.013. Epub 2012 Jan 7.
10
Rare neuroendocrine tumours: results of the surveillance of rare cancers in Europe project.罕见神经内分泌肿瘤:欧洲罕见癌症监测项目的结果。
Eur J Cancer. 2013 Jul;49(11):2565-78. doi: 10.1016/j.ejca.2013.02.029. Epub 2013 Mar 27.

引用本文的文献

1
Successful treatment with pembrolizumab for microsatellite instability-high thymic carcinoma: A case report.帕博利珠单抗成功治疗微卫星高度不稳定型胸腺癌:一例报告
Respir Med Case Rep. 2025 Jul 23;57:102272. doi: 10.1016/j.rmcr.2025.102272. eCollection 2025.
2
Surveillance of thymic epithelial tumors (TETs)-a narrative review.胸腺上皮肿瘤(TETs)的监测——一篇叙述性综述
Mediastinum. 2025 Jun 25;9:18. doi: 10.21037/med-25-20. eCollection 2025.
3
Rising Threat: Long-Term Trends in the Incidence and Mortality of Thymic Epithelial Tumor.
不断上升的威胁:胸腺上皮肿瘤发病率和死亡率的长期趋势
Cancer Med. 2025 May;14(10):e70968. doi: 10.1002/cam4.70968.
4
Treatment of thymoma with low-dose glucocorticoids before surgery for significant tumor shrinkage: A case report.术前采用低剂量糖皮质激素治疗胸腺瘤以实现显著肿瘤缩小:一例报告
World J Clin Cases. 2025 Apr 16;13(11):98979. doi: 10.12998/wjcc.v13.i11.98979.
5
Immunotherapy-Resistant Neuropathic Pain and Fatigue Predict Quality-of-Life in Contactin-Associated Protein-Like 2 Antibody Disease.免疫疗法抵抗性神经性疼痛和疲劳可预测接触蛋白相关样蛋白2抗体疾病的生活质量。
Ann Neurol. 2025 Mar;97(3):521-528. doi: 10.1002/ana.27177. Epub 2025 Jan 18.
6
Incidence, risk factors, and epidemiological trends of tracheal cancer: a global analysis.气管癌的发病率、危险因素及流行病学趋势:一项全球分析。
Mol Cancer. 2024 Dec 18;23(1):271. doi: 10.1186/s12943-024-02188-4.
7
Constitutional Factors and Irradiation as Risk Factors for Thymoma: A European Case-Control Study.体质因素与辐射是胸腺瘤的危险因素:一项欧洲病例对照研究。
Int J Environ Res Public Health. 2024 Sep 20;21(9):1241. doi: 10.3390/ijerph21091241.
8
Incidence of second malignancies in patients with thymic carcinoma and thymic neuroendocrine tumor.胸腺癌和胸神经内分泌肿瘤患者的第二恶性肿瘤发生率。
J Cancer Res Clin Oncol. 2024 Jan 16;150(1):11. doi: 10.1007/s00432-023-05522-3.
9
Prognostic factors and role of postoperative radiotherapy in surgically resected thymomas.手术切除胸腺瘤的预后因素及术后放疗的作用
JTCVS Open. 2023 Mar 3;14:561-580. doi: 10.1016/j.xjon.2023.02.013. eCollection 2023 Jun.
10
Identification of predictors of long-term survival and prognostic outcomes in thymic squamous cell carcinoma: A real-world study.胸腺鳞状细胞癌长期生存和预后结局预测因素的识别:一项真实世界研究。
Cancer Med. 2023 Jul;12(13):14025-14036. doi: 10.1002/cam4.6049. Epub 2023 Jun 17.